Gabapentin
Product Images NDC 0440-7559
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 0440-7559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Liberty Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
930a0c1e-figure-02 (Gabapentin 300 mg 270 Caps For Amneal 2)
930a0c1e-figure-03 (Gabapentin 300 mg 270 Caps For Amneal 3)
This is a medical study evaluating the efficacy of Gabapentin in reducing pain score in patients. The study includes a 3-week titration period and a 4-week fixed dose period. The study compares Gabapentin dosages of 1800 mg/day and 2400 mg/day against a Placebo control group. The result indicates that both Gabapentin dosages significantly reduced the mean pain score compared to Placebo. No further information is available.*
930a0c1e-figure-04 (Gabapentin 300 mg 270 Caps For Amneal 4)
930a0c1e-figure-05 (Gabapentin 300 mg 270 Caps For Amneal 5)
Image Label (Gabapentin 300 mg 270 Caps For Amneal 6)
This is a prescription drug called Gabapentin, with 300mg per capsule, manufactured by Amneal Pharmaceuticals of NY. The capsules are oblong-shaped and have "IP 102" imprinted on one side. It is the generic equivalent for the branded drug Neurontin. The package was labeled by Al and distributed by IDAREX PHARMACEUTICALS LLC, California. It is advised to keep it out of reach of children and store between 16-30 degrees Celsius. The prescription information is not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.